Pharmaceutical giants Eli Lilly and Company & Novo Nordisk A/S face challenges in the obesity market despite promising data.

Some of what RFK Jr. says about obesity prevention isn't new. But after having coined the catchy MAHA acronym, it’s likely ...

Berberine, green tea extract and taurine are just some of the ingredients advertised as being able to ‘boost’ GLP-1 levels.

As anti-obesity medications gain popularity, a new concern has also gained traction among researchers: increased food waste. A self-administered online survey sponsored by Ohio State found that 25% of ...

Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia ...

Patients lost an average of 20.2% of their weight with tirzepatide over 72 weeks versus 13.7% with semaglutide.

In a new guidance statement, the American Diabetes Association advises against the use of unapproved products, warning of ...

Medically reviewed by Peter Weiss, MD Ozempic is the brand name of a medication called semaglutide, a glucagon-like peptide-1 ...

While surgery has a low risk for complications, when they do occur, they are serious. This may explain why only 5%-10% of ...

A study finds that anti-obesity medications may help reduce alcohol consumption, with nearly half of participants in weight ...